• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

东亚女性乳腺癌风险中碱基切除修复基因多态性与雌激素-DNA 加合物的相互作用。

Interaction of base excision repair gene polymorphism and estrogen-DNA adducts in breast cancer risk among East Asian women.

机构信息

Department of Oncology, National Taiwan University Hospital, Yun-Lin Branch, Yun-Lin, Taiwan.

Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Breast Cancer Res Treat. 2024 Nov;208(2):283-292. doi: 10.1007/s10549-024-07418-3. Epub 2024 Jul 5.

DOI:10.1007/s10549-024-07418-3
PMID:38969945
Abstract

PURPOSE

In East Asia, the incidence of breast cancer has been increasing rapidly, particularly among premenopausal women. An elevated ratio of estrogen-DNA adducts was linked to a higher risk of breast cancer. The present study explored the influence of the interaction between base excision repair (BER) gene polymorphisms and estrogen-DNA adducts on breast cancer risk.

METHODS

We conducted a case-control study comprising healthy volunteers and individuals with benign breast disease (control arm, n = 176) and patients with invasive carcinoma or carcinoma in situ (case arm, n = 177). Genotyping for BER-related genes, including SMUG1, OGG1, ERCC5, and APEX1, was performed. A logistic regression model, incorporating interactions between gene polymorphisms, estrogen-DNA adduct ratio, and clinical variables, was used to identify the risk factors for breast cancer.

RESULTS

Univariate analysis indicated marginal associations between breast cancer risk and APEX1 rs1130409 T > G (P = 0.057) and APEX1 rs1760944 T > G (P = 0.065). Multivariate regression analysis revealed significant associations with increased breast cancer risk for APEX1_rs1130409 (GT/GG versus TT) combined with a natural logarithmic value of the estrogen-DNA adduct ratio (estimated OR 1.164, P = 0.023) and premenopausal status with an estrogen-DNA adduct ratio > 2.93 (estimated OR 2.433, P = 0.001).

CONCLUSION

APEX1_rs1130409 (GT/GG versus TT) polymorphisms, which are related to decreased BER activity, combined with an increased ratio of estrogen-DNA adducts, increase the risk of breast cancer in East Asian women.

摘要

目的

在东亚地区,乳腺癌的发病率一直在迅速上升,尤其是在绝经前女性中。雌激素-DNA 加合物水平升高与乳腺癌风险增加相关。本研究旨在探讨碱基切除修复(BER)基因多态性与雌激素-DNA 加合物之间的相互作用对乳腺癌风险的影响。

方法

我们进行了一项病例对照研究,纳入了健康志愿者和患有良性乳腺疾病的个体(对照组,n=176)以及患有浸润性癌或原位癌的患者(病例组,n=177)。对 BER 相关基因(包括 SMUG1、OGG1、ERCC5 和 APEX1)进行基因分型。采用逻辑回归模型,纳入基因多态性、雌激素-DNA 加合物比值和临床变量之间的相互作用,以确定乳腺癌的风险因素。

结果

单因素分析表明,APEX1 rs1130409 T> G(P=0.057)和 APEX1 rs1760944 T> G(P=0.065)与乳腺癌风险之间存在边缘关联。多变量回归分析显示,APEX1_rs1130409(GT/GG 与 TT)与雌激素-DNA 加合物比值的自然对数值相结合与乳腺癌风险增加显著相关(估计比值比 1.164,P=0.023),并且雌激素-DNA 加合物比值>2.93 与绝经前状态相关(估计比值比 2.433,P=0.001)。

结论

APEX1_rs1130409(GT/GG 与 TT)多态性与 BER 活性降低相关,与雌激素-DNA 加合物比值升高相结合,增加了东亚女性患乳腺癌的风险。

相似文献

1
Interaction of base excision repair gene polymorphism and estrogen-DNA adducts in breast cancer risk among East Asian women.东亚女性乳腺癌风险中碱基切除修复基因多态性与雌激素-DNA 加合物的相互作用。
Breast Cancer Res Treat. 2024 Nov;208(2):283-292. doi: 10.1007/s10549-024-07418-3. Epub 2024 Jul 5.
2
Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population.碱基切除修复基因遗传多态性对韩国人群乳腺癌发病风险的影响。
Gene. 2013 Dec 15;532(2):192-6. doi: 10.1016/j.gene.2013.09.069. Epub 2013 Sep 25.
3
Association of polymorphisms in base excision repair genes with the risk of breast cancer: a case-control study in North Indian women.碱基切除修复基因多态性与乳腺癌风险的关联:一项针对北印度女性的病例对照研究。
Oncol Res. 2008;17(3):127-35. doi: 10.3727/096504008785055567.
4
Polymorphisms in three base excision repair genes and breast cancer risk in Thai women.泰国女性中三个碱基切除修复基因的多态性与乳腺癌风险
Breast Cancer Res Treat. 2008 Sep;111(2):279-88. doi: 10.1007/s10549-007-9773-7. Epub 2007 Oct 6.
5
Association of APEX1 and OGG1 gene polymorphisms with breast cancer risk among Han women in the Gansu Province of China.中国甘肃省汉族女性中APEX1和OGG1基因多态性与乳腺癌风险的关联
BMC Med Genet. 2018 May 2;19(1):67. doi: 10.1186/s12881-018-0578-9.
6
A polymorphism in the DNA repair domain of APEX1 is associated with the radiation-induced pneumonitis risk among lung cancer patients after radiotherapy.APEX1基因DNA修复结构域的多态性与肺癌患者放疗后放射性肺炎的发生风险相关。
Br J Radiol. 2014 Aug;87(1040):20140093. doi: 10.1259/bjr.20140093. Epub 2014 Jun 2.
7
Single nucleotide polymorphisms of DNA base-excision repair genes (APE1, OGG1 and XRCC1) associated with breast cancer risk in a Chinese population.中国人群中与乳腺癌风险相关的DNA碱基切除修复基因(APE1、OGG1和XRCC1)的单核苷酸多态性。
Asian Pac J Cancer Prev. 2014;15(3):1133-40. doi: 10.7314/apjcp.2014.15.3.1133.
8
Association of the rs1760944 polymorphism in the APEX1 base excision repair gene with risk of nasopharyngeal carcinoma in a population from an endemic area in South China.中国南方某流行地区人群中,APEX1碱基切除修复基因rs1760944多态性与鼻咽癌风险的关联。
J Clin Lab Anal. 2018 Feb;32(2). doi: 10.1002/jcla.22238. Epub 2017 May 2.
9
Analysis of Polymorphisms Associated with Base Excision Repair in Patients Susceptible and Resistant to Noise-Induced Hearing Loss.易感性和抗性噪声性听力损失患者碱基切除修复相关多态性分析。
Dis Markers. 2019 Nov 14;2019:9327106. doi: 10.1155/2019/9327106. eCollection 2019.
10
Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.碱基切除修复基因 XRCC1 和 APEX1 的功能多态性可预测接受根治性放疗的非小细胞肺癌患者放射性肺炎的风险。
Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):e67-73. doi: 10.1016/j.ijrobp.2010.11.079. Epub 2011 Mar 21.

引用本文的文献

1
Genetic Polymorphisms in Base Excision Repair (BER) and Nucleotide Excision Repair (NER) Pathways as Potential Biomarkers for Gynecological Cancers: A Comprehensive Literature Review.碱基切除修复(BER)和核苷酸切除修复(NER)途径中的基因多态性作为妇科癌症的潜在生物标志物:一项综合文献综述
Cancers (Basel). 2025 Jun 27;17(13):2170. doi: 10.3390/cancers17132170.